...
首页> 外文期刊>Nature Communications >Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases
【24h】

Leveraging heterogeneity across multiple datasets increases cell-mixture deconvolution accuracy and reduces biological and technical biases

机译:利用多个数据集的异质性可提高细胞混合物反卷积的准确性,并减少生物学和技术上的偏见

获取原文
           

摘要

In silico quantification of cell proportions from mixed-cell transcriptomics data (deconvolution) requires a reference expression matrix, called basis matrix. We hypothesize that matrices created using only healthy samples from a single microarray platform would introduce biological and technical biases in deconvolution. We show presence of such biases in two existing matrices, IRIS and LM22, irrespective of deconvolution method. Here, we present immunoStates, a basis matrix built using 6160 samples with different disease states across 42 microarray platforms. We find that immunoStates significantly reduces biological and technical biases. Importantly, we find that different methods have virtually no or minimal effect once the basis matrix is chosen. We further show that cellular proportion estimates using immunoStates are consistently more correlated with measured proportions than IRIS and LM22, across all methods. Our results demonstrate the need and importance of incorporating biological and technical heterogeneity in a basis matrix for achieving consistently high accuracy.
机译:在计算机上根据混合细胞转录组学数据(反卷积)对细胞比例进行量化时,需要参考表达矩阵,即基础矩阵。我们假设仅使用来自单个微阵列平台的健康样本创建的矩阵会在反卷积中引入生物学和技术偏见。我们展示了在两个现有矩阵IRIS和LM22中存在这种偏差的情况,与反卷积方法无关。在这里,我们介绍了免疫状态,这是一个基于42个微阵列平台的6160个具有不同疾病状态的样本构建的基础矩阵。我们发现免疫状态显着降低了生物学和技术偏见。重要的是,我们发现选择基本矩阵后,不同的方法几乎没有效果或影响很小。我们进一步表明,在所有方法中,使用I-免疫状态的细胞比例估计值与IRIS和LM22相比,与测量比例的相关性始终更高。我们的结果表明,将生物学和技术异质性纳入基础矩阵中以实现始终如一的高精度的必要性和重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号